Lumis blog posts
Decentralized Clinical trials – oversight and vendor management
The concepts around decentralized or virtual clinical trials have been extensively developed over the last years. Especially with the start of the COVID-19 pandemic, companies have been faced with new challenges: to keep the patients in their ongoing clinical trials or even to recruit new patients for the studies. Regulatory authorities adjusted quickly to support new approaches to clinical trials and the concepts of decentralized clinical trials experienced a large upswing.
Decentralized Clinical trials – oversight and vendor management Read more
Key Performance Indicators for effective Clinical Trial Oversight Management
Most companies outsource their clinical trial activities, however it is the sponsor who is entirely responsible for the clinical trial performance. Without mirroring the work of the CRO
Key Performance Indicators for effective Clinical Trial Oversight Management Read more
Sponsor-vendor relationship – it takes two to tango (at least)
The number of small Biopharmaceutical and Medical Device Companies (“small sponsor companies”) conducting early stage clinical trials is increasing. Outsourcing and vendor management are essential for survival of these companies, since they are usually facing the challenges of limited budgets and resources.
Sponsor-vendor relationship – it takes two to tango (at least) Read more
Are you ready to outsource your clinical trial?
Outsourcing of clinical research to a CRO or other vendors is a critical business process with a high impact on the outsourcing company and its procedures, especially for small sponsor companies.